MedPath

MICHAEL PORTMAN

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease

Phase 2
Completed
Conditions
Mucocutaneous Lymph Node Syndrome
Kawasaki Disease
Interventions
Drug: Placebo
First Posted Date
2009-02-11
Last Posted Date
2023-05-06
Lead Sponsor
Michael Portman
Target Recruit Count
205
Registration Number
NCT00841789
Locations
🇺🇸

Texas Children's Hospital, Houston, Texas, United States

🇺🇸

Seattle Children's Hospital, Seattle, Washington, United States

🇺🇸

Primary Children's Medical Center, Salt Lake City, Utah, United States

and more 5 locations

Study of Triostat in Infants During Heart Surgery

Phase 3
Completed
Conditions
Heart Defects, Congenital
Interventions
Procedure: Cardiopulmonary bypass and cardiac surgery
First Posted Date
2001-12-07
Last Posted Date
2013-08-05
Lead Sponsor
Michael Portman
Target Recruit Count
195
Registration Number
NCT00027417
Locations
🇺🇸

Children's Hospital and Regional Medical Center, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath